Moxonidine: A Second‐generation Central Antihypertensive Agent
- 1 December 1993
- journal article
- Published by Wiley in Cardiovascular Drug Reviews
- Vol. 11 (4) , 411-431
- https://doi.org/10.1111/j.1527-3466.1993.tb00198.x
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- Lack of Pharmacokinetic Interactions Between Moxonidine and DigoxinClinical Pharmacokinetics, 1992
- Determination of moxonidine (BDF 5895) in plasma by gas chromatography—negative ion chemical ionization mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 1992
- Guanfacine: A Second Generation α2-Adrenergic BlockerThe Lancet Healthy Longevity, 1990
- The imidazoline-preferring receptorLife Sciences, 1989
- The Influence of Renal Function on Clinical Pharmacokinetics of MoxonidineClinical Pharmacokinetics, 1988
- Sympathetic Neural and α‐Adrenergic Modulation of ArrhythmiasaAnnals of the New York Academy of Sciences, 1988
- Pharmacokinetics of Moxonidine After Single and Repeated Daily Doses in Healthy VolunteersThe Journal of Clinical Pharmacology, 1987
- Evidence for imidazoline binding sites in basolateral membranes from rabbit kidneyBiochemical and Biophysical Research Communications, 1987
- Comparison of Moxonidine and Clonidine HCl in Treating Patients With HypertensionThe Journal of Clinical Pharmacology, 1987
- Interrelationships between clonidine and histaminergic mechanismsTrends in Pharmacological Sciences, 1981